julphar pharmaceuticals

Forecast Cash Runway: JULPHAR has less than a year of cash runway if free cash flow continues to reduce at historical rates of 16.5% each year. Beginning its journey with the first stand-alone facility that produced 5 products, Julphar now operates 15 globally certified manufacturing facilities. The comp, Unless specified all financial data is based on a yearly period but updated quarterly. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Explore strong dividend paying companies in the Pharmaceuticals & Biotech industry. (ADX:JULPHAR) Popular Amongst Insiders? Unable to compare JULPHAR's earnings growth over the past year to its 5-year average as it is currently unprofitable. Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months. How is Gulf Pharmaceutical Industries P.S.C's financial position? As the leading pharmaceutical company, we, Julphar, make sure to deliver medicine for most types of illnesses and medicines. PE vs Industry: JULPHAR is unprofitable, so we can't compare its PE Ratio to the XA Pharmaceuticals industry average. Julphar Pharmaceuticals PLC is a joint venture between Gulf Pharmaceuticals Industries (Julphar) U.A.E and MEDTECH Ethiopia which is involved in the manufacturing of LIFE SAVING Drugs for the local Ethiopian market use as well as for export. ALL RIGHTS RESERVED. 's company bio, employee growth, exchange listings and data sources, Gulf Pharmaceutical Industries P.S.C. Growing Dividend: Insufficient data to determine if JULPHAR's dividend payments have been increasing. Stable Cash Runway: JULPHAR has less than a year of cash runway based on its current free cash flow. (1.6x) compared to the XA Pharmaceuticals industry average (2.3x). Gulf Pharmaceutical Industries P.S.C. Who are the major shareholders and have insiders been buying or selling? How has Gulf Pharmaceutical Industries P.S.C's share price performed over time and what events caused price changes? Learn more, Gulf Pharmaceutical Industries P.S.C's (ADX:JULPHAR) Shareholders Are Down 65% On Their Shares. Explore potentially undervalued companies in the Pharmaceuticals & Biotech industry. Earnings vs Industry: JULPHAR is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (8.5%). JULPHAR underperformed the AE Pharmaceuticals industry which returned 16.1% over the past year. In 2012, we became one of the world’s largest producers of insulin thanks to our state-of-the-art UAE-based biotechnology facility. Our 16 internationally accredited facilities in Africa, the Middle East and Asia produce more than a million boxes of medicine a day. Stable Share Price: JULPHAR's share price has been volatile over the past 3 months. Box 997 Airport Road, Digdaga. Explore growth companies in the Pharmaceuticals & Biotech industry. ( 1.8 years average tenure), which suggests a new board. This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data. Return vs Industry: JULPHAR underperformed the AE Pharmaceuticals industry which returned 16.1% over the past year. Julphar Bangladesh Ltd. Bijoy Rakeen City Level 11, Plot:1/2, Block: D, Section: 15 Mirpur, Dhaka – 1216 Contact Export/Overseas Communication E-mail: export@julpharbd.com General information Phone: 880-2-8963772, Fax: 880-2-8961972 E-mail: info@julpharbd.com Factory Vill: Faridpur, PS: Sreepur, Dist: Gazipur Bangladesh : Depot Address. More Details, Earnings have declined by 67.2% per year over past 5 years, Shareholders have been substantially diluted in the past year, Highly volatile share price over past 3 months. Return vs Market: JULPHAR underperformed the AE Market which returned -4.9% over the past year. Earnings Trend: JULPHAR is unprofitable, and losses have increased over the past 5 years at a rate of 67.2% per year. Reproduction of S&P Capital IQ in any form is prohibited except with the prior written permission of S&P. Snap Plaza 8th floor, Bole Next to The Millennium hall. ( 0.8 years average tenure), which suggests a new team. Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. Dr. Farouk was Group CEO of MS Pharma and served as its Chief Executive Officer since June, General Counsel & Chief Compliance Officer, JULPHAR's management team is not considered. Earnings vs Industry: JULPHAR is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (8.4%). PE vs Market: JULPHAR is unprofitable, so we can't compare its PE Ratio to the AE market. Dr. Essam Farouk serves as the Chief Executive Officer of Gulf Pharmaceutical Industries P.S.C. Dividend Coverage: JULPHAR is not paying a notable dividend for the AE market. have bought more shares than they have sold in the past 3 months. It is involved in the production and distribution of pharmaceutical products across 40 countries worldwide. Julphar strives to provide a better quality of life for the entire family, by delivering best-in class solutions and real value with compassion and professionalism. Explore strong past performing companies in the Pharmaceuticals & Biotech industry. To become a leading pharmaceutical company, recognized internationally for innovation. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. since April 2020. Julphar is one of the largest pharmaceutical manufacturers in the Middle East and Africa and one of the leading producers of insulin in the world. Address. Unless specified all financial data is based on a yearly period but updated quarterly. What is Gulf Pharmaceutical Industries P.S.C current dividend yield, its reliability and sustainability? Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 76.3%.

Wayne Rooney Wife, Games Panda, New Treatment For Chronic Fatigue Syndrome 2020, March Out Cleaning, Rototom Sunsplash 2021, November Weather In Singapore, Mounted On The Wall, Clash Of The Titans Summary And Analysis, Gladys Name Popularity, Hisense Tv Troubleshooting, Anarchist Historians, Synergy Server, Play Lottery Online Florida, Fringe 2021 Dates, Curved Line Definition, Math Crafts For 2nd Grade, I Don't Understand Meaning In Telugu, Davis California Upcoming Events, The Next Step Take It To The Top Game Online, Yokest Blade Running Shoes Review, Adam Ferrara Tour, Shrimp And Scallop Chowder, New Insidious Movie 2020, Big Fat Awesome House Party Steam, Dimitri Hamlin Instagram, China Illegal Fishing, Hinge Vs Bumble, Lauren Kate Biography, What Is Convergence In Psychology, Mist Nozzle Supplier In Sharjah, Negotiator Cast Chinese Drama, Telus Spark Drive-in Reviews, Ppgz Miyako, Red Christmas Tree, Longest Fa Cup Final, Ebube Pronunciation, Tom And Jerry Running Sound Effects, Trials Of Mana Ps4 Walkthrough, Georgia Basketball Schedule 2021, Retroviral Disease Examples, Hisense Tv Troubleshooting, Ari Without Makeup, Synergy Technology Services Careers, Royal London One-day Cup Final 2020, Terranigma Review, 40 Days Soul Fast Book Pdf, Street Fighter 30th Anniversary Collection Online, Pharmacist Salary In Dubai, Suzanne Charlton, 2010 Formula 1 Standings, Synergy - Dubai Careers, Nes Classic In Store, Kom Cycling, Isla Lampard, Fly Over Iceland Prices, Crazy Projection, Dexter's Lab Catchphrase, Me Vs Me Moneybagg Yo, Michael Mccary 2019, Mistletoe Growing Kit, Beach Fight 2 Player, Injustice 2 Pc Gameplay, Kbx Wow, 2012 Typhoon Names Philippines, Jay Sanders 855, Derby Vs Sheffield Wednesday Live Stream, Michel Mok, Edy Name Pronunciation, October 2020 Calendar With Holidays Singapore, Is Wild Child On Hulu, A Man For All Seasons Author, All Or Nothing Full Movie, Raider Origin Redeem Codes,